MC3138 free base · Synonyms: MC-3138 · MC 3138
MC3138 is a selective SIRT5 activator.
For research use only. Not for human or veterinary use.
Purity >98%
Stock Inquire
MC3138 structure
CAS No.: 1844889-12-8
Pack sizes & pricing
| Size | Price | SKU | Stock | |
|---|---|---|---|---|
| 100 mg | USD 465.00 | BP-01936-100mg | In stock | Get quote |
| 250 mg | USD 685.00 | BP-01936-250mg | In stock | Get quote |
| 500 mg | USD 985.00 | BP-01936-500mg | In stock | Get quote |
| 1 g | Inquire | BP-01936-1g | In stock | Inquire |
Need another size or custom synthesis? Request a quote.
Description
MC3138 is a selective SIRT5 activator. MC3138 has antitumor activity on human PDAC cells, with IC50 values of 25.4-236.9 μM. MC3138 combined with Gemcitabine significantly inhibits tumor growth in mice .
Biological activity
MC3138 (10 μM, 24 h) decreases lysine acetylation of the GOT1 protein and inhibits its enzymatic activity in PDAC cells[1].
Identifiers
- SMILES
-
CCOC(=O)C1=CN(C=C(C1C2=CC(=CC=C2)OC)C(=O)OCC)C(=O)C3=CC=CC=C3 - InChIKey
-
WDDDSHYKJNGLJR-UHFFFAOYSA-N
Specifications
- MW (average)
- 435.4691
- Formula
- C25H25NO6
- CAS No.
- 1844889-12-8
- Physical state
- Solid
- Color
- White to off-white
- Shipping
- Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
- Storage
- Powder -20℃, sealed, 3 years; 4℃, sealed, 2 years; In solvent -20℃ 1 month;
Solubility
soluble in DMSO, >50 mg/mL
Documents
References
[1]. Hu T, et al. Metabolic Rewiring by Loss of Sirt5 Promotes Kras-Induced Pancreatic Cancer Progression. Gastroenterology. 2021 Nov;161(5):1584-1600.
Same research area
Search Cancer- BP-01858A Derazantinib hydrochloride salt · >98%
- BP-01861A Nirogacestat dihydrobromide salt · >98%
- BP-01900A IACS-010759 HCl salt · >98%
- BP-01923 Avapritinib free base · >98%
- BP-01924 BLU-554 free base · >99%
- BP-01925 ACY-1083 free base · >98%
- BP-01927 PHGDH-IN-5 free base · >98%
- BP-01928 Bortezomib free base · >99%